Registration Decision RD2021-06, Fluazaindolizine and Salibro Nematicide
This decision is consistent with the Proposed Registration Decision PRD2021-03, Fluazaindolizine and Salibro Nematicide, whichcontains a detailed evaluation of the information submitted in support of this registration.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Registration Decision RD2021-06, Fluazaindolizine and Salibro NematicideHTMLEnglish publication HTML
-
Registration Decision RD2021-06, Fluazaindolizine and Salibro NematicideHTMLFrench publication HTML
Similar records